Geode Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.1M Buy
1,399,610
+72,991
+6% +$2.3M ﹤0.01% 1495
2025
Q1
$43.5M Sell
1,326,619
-183,949
-12% -$6.03M ﹤0.01% 1455
2024
Q4
$54.6M Buy
1,510,568
+28,517
+2% +$1.03M ﹤0.01% 1382
2024
Q3
$46.2M Buy
1,482,051
+74,438
+5% +$2.32M ﹤0.01% 1475
2024
Q2
$37.7M Buy
1,407,613
+100,663
+8% +$2.69M ﹤0.01% 1546
2024
Q1
$44.6M Buy
1,306,950
+61,796
+5% +$2.11M ﹤0.01% 1431
2023
Q4
$36M Buy
1,245,154
+152,057
+14% +$4.4M ﹤0.01% 1544
2023
Q3
$30.1M Buy
1,093,097
+38,951
+4% +$1.07M ﹤0.01% 1555
2023
Q2
$31.7M Buy
1,054,146
+16,653
+2% +$501K ﹤0.01% 1547
2023
Q1
$37.6M Buy
1,037,493
+30,946
+3% +$1.12M ﹤0.01% 1382
2022
Q4
$35.9M Buy
1,006,547
+57,637
+6% +$2.06M 0.01% 1378
2022
Q3
$32.1M Buy
948,910
+9,769
+1% +$331K ﹤0.01% 1400
2022
Q2
$27.2M Buy
939,141
+9,134
+1% +$264K ﹤0.01% 1541
2022
Q1
$30.1M Sell
930,007
-31,701
-3% -$1.02M ﹤0.01% 1609
2021
Q4
$28M Buy
961,708
+12,695
+1% +$370K ﹤0.01% 1730
2021
Q3
$25.3M Buy
949,013
+43,322
+5% +$1.16M ﹤0.01% 1785
2021
Q2
$27.9M Buy
905,691
+36,067
+4% +$1.11M ﹤0.01% 1744
2021
Q1
$22.8M Buy
869,624
+74,193
+9% +$1.94M ﹤0.01% 1794
2020
Q4
$20M Buy
795,431
+32,373
+4% +$815K ﹤0.01% 1717
2020
Q3
$15.9M Sell
763,058
-9,849
-1% -$205K ﹤0.01% 1686
2020
Q2
$18.4M Buy
772,907
+14,564
+2% +$346K ﹤0.01% 1572
2020
Q1
$13.6M Buy
758,343
+42,959
+6% +$773K ﹤0.01% 1547
2019
Q4
$17M Buy
715,384
+20,299
+3% +$481K ﹤0.01% 1667
2019
Q3
$19.1M Buy
695,085
+19,319
+3% +$531K ﹤0.01% 1519
2019
Q2
$22.4M Buy
675,766
+40,936
+6% +$1.35M 0.01% 1413
2019
Q1
$22.2M Buy
634,830
+46,571
+8% +$1.63M 0.01% 1347
2018
Q4
$19.5M Buy
588,259
+44,268
+8% +$1.47M 0.01% 1296
2018
Q3
$27.4M Buy
543,991
+17,366
+3% +$874K 0.01% 1180
2018
Q2
$31.5M Buy
526,625
+27,136
+5% +$1.62M 0.01% 1034
2018
Q1
$22.9M Buy
499,489
+34,749
+7% +$1.59M 0.01% 1170
2017
Q4
$18.5M Buy
464,740
+15,489
+3% +$617K 0.01% 1313
2017
Q3
$18M Sell
449,251
-5,158
-1% -$206K 0.01% 1326
2017
Q2
$19.6M Buy
454,409
+6,585
+1% +$284K 0.01% 1200
2017
Q1
$14M Buy
447,824
+69,395
+18% +$2.17M 0.01% 1413
2016
Q4
$9.55M Buy
378,429
+33,954
+10% +$857K ﹤0.01% 1614
2016
Q3
$8.52M Buy
344,475
+68,393
+25% +$1.69M ﹤0.01% 1596
2016
Q2
$5.62M Buy
276,082
+39,895
+17% +$813K ﹤0.01% 1831
2016
Q1
$3.6K Sell
236,187
-49,772
-17% -$759 ﹤0.01% 2086
2015
Q4
$3.84M Buy
285,959
+2,418
+0.9% +$32.5K ﹤0.01% 2046
2015
Q3
$3.98M Buy
283,541
+44,852
+19% +$629K ﹤0.01% 1987
2015
Q2
$4.05M Buy
238,689
+84,484
+55% +$1.43M ﹤0.01% 2052
2015
Q1
$1.86M Buy
154,205
+7,185
+5% +$86.9K ﹤0.01% 2486
2014
Q4
$1.22M Buy
147,020
+522
+0.4% +$4.33K ﹤0.01% 2722
2014
Q3
$1.27M Buy
146,498
+5,759
+4% +$50K ﹤0.01% 2638
2014
Q2
$1.54M Buy
140,739
+55,205
+65% +$604K ﹤0.01% 2537
2014
Q1
$764K Buy
85,534
+5,819
+7% +$52K ﹤0.01% 2936
2013
Q4
$601K Buy
79,715
+19,202
+32% +$145K ﹤0.01% 2997
2013
Q3
$444K Buy
60,513
+2,036
+3% +$14.9K ﹤0.01% 3005
2013
Q2
$376K Buy
+58,477
New +$376K ﹤0.01% 3004